CymaBay Therapeutics announced that it has commenced an underwritten public offering of its common stock and pre-funded warrants. Piper Sandler, Raymond James and Cantor are acting as the joint book-running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CBAY:
- CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
- CymaBay Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- CymaBay collaboration in Japan further de-risks PBC data, says Piper Sandler
- CymaBay announces collaboration with Kaken to develop, commercialize Seladelpar
- CymaBay Therapeutics Announces Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis